Data spanning the past 90 days through February 19, 2026 reveals that Galectin Therapeutics's three principal insider shareholders consist of Director Richard E Uihlein (10.33Mn shares), TenPercentOwner James C Czirr (5.92Mn shares), TenPercentOwner Fund, L.P. 10x (5.67Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Richard E Uihlein | 10,332,676 | 21 Jan, 2026 | |
| James C Czirr | 5,922,207 | 25 Apr, 2024 | |
| Fund, L.P. 10x | 5,670,138 | 08 Dec, 2025 | |
| Joel Lewis | President And Ceo | 778,260 | 13 Jan, 2026 |
| Kevin D Freeman | 135,269 | 23 Dec, 2025 | |
| Kary Eldred | 65,682 | 09 Feb, 2026 | |
| Richard A. Jr. Zordani | 44,083 | 26 Dec, 2024 | |
| Jack W Callicutt | Chief Financial Officer | 7,614 | 06 Jan, 2026 |
| Harold H. Shlevin | 6,500 | 19 Dec, 2025 | |
| Elissa J. Schwartz | 1,000 | 24 Jan, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Feb, 2026 | Kary Eldred | Common Stock | A | 300 | $2.70 | 65,682 | D | P |
| 16 Jan, 2026 | Richard E Uihlein | Common Stock | A | 13,158 | $3.04 | 10,332,676 | D | A |
| 06 Jan, 2026 | Jack W Callicutt | Common Stock | D | 20,354 | $3.67 | 7,614 | D | S |
| 06 Jan, 2026 | Joel Lewis | Common Stock | D | 37,698 | $3.58 | 832,592 | D | S |
| 06 Jan, 2026 | Khurram Jamil | Common Stock | D | 21,446 | $3.65 | 0 | D | S |
| 05 Jan, 2026 | Jack W Callicutt | Common Stock | D | 25,732 | $3.90 | 27,968 | D | S |
| 05 Jan, 2026 | Joel Lewis | Common Stock | D | 27,731 | $3.91 | 870,290 | D | S |
| 05 Jan, 2026 | Joel Lewis | Common Stock | D | 56,332 | $3.88 | 776,260 | D | |
| 05 Jan, 2026 | Khurram Jamil | Common stock | D | 25,499 | $3.90 | 21,446 | D | S |
| 02 Jan, 2026 | Jack W Callicutt | Common Stock | D | 13,914 | $4.20 | 53,700 | D | S |
| 02 Jan, 2026 | Jack W Callicutt | Common Stock | A | 60,000 | $0.00 | 67,614 | D | M |
| 02 Jan, 2026 | Joel Lewis | Common Stock | A | 84,000 | $0.00 | 916,592 | D | M |
| 02 Jan, 2026 | Joel Lewis | Common Stock | D | 18,571 | $4.20 | 898,021 | D | S |
| 02 Jan, 2026 | Khurram Jamil | Common Stock | D | 13,055 | $4.20 | 46,945 | D | S |
| 02 Jan, 2026 | Khurram Jamil | Common Stock | A | 60,000 | $0.00 | 60,000 | D | M |
| 31 Dec, 2025 | Khurram Jamil | Common Stock | D | 8,125 | $4.07 | 0 | D | S |
| 31 Dec, 2025 | Khurram Jamil | Common Stock | A | 8,125 | $1.23 | 8,125 | D | M |
| 23 Dec, 2025 | Kevin D Freeman | - | - | 55,269 | D | |||
| 23 Dec, 2025 | Kevin D Freeman | Common Stock | A | 5,500 | $3.55 | 55,269 | D | P |
| 23 Dec, 2025 | Kevin D Freeman | Common Stock | A | 5,500 | $3.55 | 55,269 | D | P |